Home / Brands / PharMEDium Services
PharMEDium Services Recalls
291 recalls on record · September 2, 2015 to April 15, 2020 · Drugs
Recalls by year
15
16
17
18
19
20
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 4 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride 50 mL in 60 mL Monoject S
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 4 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Hosp
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 3.5 mcg/mL Fentanyl Citrate and 0.0625%Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 125 mL in 150 mL Bax
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 3 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 100 mL in 100 mL Yello
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 3 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Hospira
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 3 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Hosp
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 3 mcg/mL Fentanyl Citrate and 0.01% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Baxte
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 20 mcg/mL HYDROmorphone HCl and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Yel
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 20 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 ml in 100 mL Yello
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 20 mcg/mL HYDROmorphone HCl and 0.075% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Bax
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 20 mcg/mL HYDROmorphone HCl and 0.06% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 55 mL in 60 mL Monoje
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 20 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 150 mL Baxt
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2.5 mcg/mL Fentanyl Citrate and 0.15% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Baxt
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2.5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Smi
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2.5 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 200 mL in 250 mL Baxte
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2.5 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Ye
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2.5 mcg/mL Fentanyl Citrate and 0.0312% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Ho
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.25% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Hospir
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.2% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Baxter
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.167% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 200 mL in 250 mL Baxte
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.162% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Yello
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.16% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 150 mL Baxte
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.15% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 200 mL in 250 mL Baxte
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; Service Code 2H8125
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Service Code 2C8201 , NDC 61553-20
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.083% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Yello
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.08% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Hospir
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 130 mL in 150 mL Baxte
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 150 mL in 150 mL Baxt
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 2 mcg/mL Fentanyl Citrate and 0.06% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Hospi
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.